OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Federal Circuit Sides With Abbott in Biaxin XL Case Against Andrx | Main | Supreme Court Reshapes Declaratory Judgment Jurisdiction in Patent Cases »

January 08, 2007

LSI's Biotechnology 2007 Conference, January 28-29, 2007, San Francisco

Law Seminars International will present its "Biotechnology 2007: Key Legal and Business Developments" conference January 28-29, 2007, in San Francisco.  Speakers include outside and inside counsel, biotechnology industry executives, and financiers.

The first day of the conference will focus on legal developments important to the biotechnology industry, while the second day will focus on business and financing issues.  Specific talks of interest include:

  • "New Developments and the Realities of Dealing with the FDA in Today's Regulatory Environment"
  • "Is a Thriving Generic Biotechnology Industry Just Around the Corner?" (which I'll be presenting)
  • "Recent Federal Circuit and Supreme Court Cases Affecting Biotech Companies"
  • "Understanding the Venture Capital Climate for Biotechs Today:  What Are VC's Looking For?"
  • "Comprehensive IP Strategies: Understanding the Ins and Outs of Your IP"

The full program is available here.  Additional details and registration information are available on the conference website.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.